Tenofovir, emtricitabine, lopinavir/r

DRUG2 trials

Sponsors

Hospital Clinic of Barcelona

Conditions

HIV Infection

Phase 4

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

CompletedNCT01533272

Hospital Clinic of BarcelonaHIV Infection

Start: 2012-02-29End: 2014-06-30Updated: 2015-04-01

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

CompletedNCT01576731

Hospital Clinic of BarcelonaHIV Infection

Start: 2012-07-31End: 2014-07-31Updated: 2015-04-01

Related Papers

A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.

2016-03-1817 citations

A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection

Journal of Antimicrobial Chemotherapy2016-03-1815 citations